Aloja 12.5 Tablet

Aloja 12.5 Tablet is a prescription diabetes medicine that contains 12.5 mg of alogliptin in each tablet. It belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class and is used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. Aloja 12.5 Tablet is not insulin and is not used to treat type 1 diabetes or diabetic ketoacidosis. This Indoco Remedies product is supplied as tablets in a strip/box of 10 packs, making it a practical oral option for ongoing diabetes management.

How it works: Alogliptin helps the body release more insulin after meals and lowers the amount of sugar the liver puts into the blood. As a tablet, Aloja 12.5 Tablet is swallowed and absorbed through the digestive tract, then works by blocking the DPP-4 enzyme to support steadier blood sugar control.

Aloja 12.5 Tablet is a lower-strength alogliptin tablet than Aloja 25 Tablet, so it may suit people who need a reduced dose based on kidney function, tolerance, or the prescriber’s treatment plan. Because it is a prescription-strength tablet, it does not work faster or more strongly just because it is taken more often; the dose is chosen to fit the patient’s needs, not to be self-adjusted.

• Type 2 diabetes
• Blood sugar control with diet and exercise
• Add-on treatment when one medicine is not enough
• Prescription management of hyperglycemia

• Swallow the Aloja 12.5 Tablet whole with water; do not crush, chew, or split it unless your prescriber says it is okay.
• Take it once daily at the same time each day for best routine adherence.
• It can usually be taken with or without food.
• If you miss a dose, take it when you remember unless it is close to the next dose; do not double up.
• Use it exactly as prescribed, especially if you have kidney problems or are taking other diabetes medicines.

Each Aloja 12.5 Tablet provides 12.5 mg of alogliptin per tablet. It is usually taken once daily, and the maximum daily amount depends on the individual prescription and kidney function; your doctor decides the right dose for you. Do not increase the dose on your own, and do not assume Aloja 12.5 Tablet is interchangeable with Aloja 25 Tablet without medical guidance.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Alogliptin may include:

• Runny or stuffy nose
• Sore throat
• Headache
• Mild diarrhea
• Back pain
• Mild flu-like symptoms

• Tell your doctor if you have kidney disease, because alogliptin dosing may need adjustment.
• Use caution if you have a history of heart failure or fluid retention.
• Do not use this tablet to treat type 1 diabetes or diabetic ketoacidosis.
• Alcohol can make blood sugar harder to predict, especially if you also take other diabetes medicines.
• Be careful when driving or operating machinery if you develop low blood sugar symptoms.
• Tell your clinician about any past pancreatitis or severe joint pain with diabetes medicines.
• If you take other glucose-lowering medicines, your risk of hypoglycemia may be higher.

• Insulin
• Sulfonylureas such as glipizide or glyburide
• Other diabetes medicines that can lower blood sugar
• Medicines that affect kidney function or require renal dose adjustment
• Alcohol

Store Aloja 12.5 Tablet at room temperature in its original strip/box, away from moisture, heat, and direct light.